Trial site
SP ZOZ Szpital Uniwersytecki w Krakowie
- 10running trials
- 7closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Ankylosing spondylitis3 trials
- Alzheimer disease2 trials
- Coronary artery disease2 trials
- Schizophrenia2 trials
- Acute myeloid leukaemia1 trial
- ALS (motor neurone disease)1 trial
- COPD1 trial
- Cushing's syndrome1 trial
- Heart failure1 trial
- Idiopathic pulmonary fibrosis1 trial
- Kidney cancer1 trial
- Multiple sclerosis1 trial
- and 4 more
- Phase
- Phase 27 trials
- Phase 35 trials
- Phase 43 trials
- Status
- Recruiting6 trials
- Completed5 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- CARE ARTHRITIS LTD.2 trials
- Jagiellonian University2 trials
- MapLight Therapeutics2 trials
- Celgene1 trial
- Charite Universitaetsmedizin Berlin KöR1 trial
- and 9 more
Running trials
Not yet recruiting
Enrolling by invitation
An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
Recruiting
PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery Trial (PREVENT-MINS)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease2 recruiting
- Ankylosing spondylitis2 recruiting
- Schizophrenia2 recruiting
- ALS (motor neurone disease)1 recruiting
- Heart failure1 recruiting
- Multiple sclerosis1 recruiting
- Ovarian cancer1 recruiting
- Psoriasis1 recruiting
- Psoriatic arthritis1 recruiting
Closed trials
Completed
Terminated
Completed
Recruiting
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Completed
Completed
Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026